NeuroPace (NPCE) Free Cash Flow (2020 - 2026)
NeuroPace has reported Free Cash Flow over the past 7 years, most recently at -$6.0 million for Q1 2026.
- For Q1 2026, Free Cash Flow rose 20.21% year-over-year to -$6.0 million; the TTM value through Mar 2026 reached -$9.5 million, up 46.87%, while the annual FY2025 figure was -$11.0 million, 38.51% up from the prior year.
- Free Cash Flow for Q1 2026 was -$6.0 million at NeuroPace, down from $494000.0 in the prior quarter.
- Over five years, Free Cash Flow peaked at $494000.0 in Q4 2025 and troughed at -$11.4 million in Q1 2022.
- A 5-year average of -$5.4 million and a median of -$4.7 million in 2024 define the central range for Free Cash Flow.
- Biggest five-year swings in Free Cash Flow: tumbled 92.45% in 2022 and later soared 110.47% in 2025.
- Year by year, Free Cash Flow stood at -$7.5 million in 2022, then skyrocketed by 56.55% to -$3.3 million in 2023, then plummeted by 44.36% to -$4.7 million in 2024, then soared by 110.47% to $494000.0 in 2025, then plummeted by 1317.41% to -$6.0 million in 2026.
- Business Quant data shows Free Cash Flow for NPCE at -$6.0 million in Q1 2026, $494000.0 in Q4 2025, and -$1.9 million in Q3 2025.